Menu
Not yet recruiting NCT06935006

Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL

No phase Interventional Percutaneous Nephrolithotomy (PCNL)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Sonographic guided Erector spinae plane block, Intravenous opioid.
Who it may be relevant to
Registry conditions: Percutaneous Nephrolithotomy (PCNL). Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Sonographic Guided Erector Spinae Plane Block Versus Conventional Analgesia After Percutaneous Nephrolithotomy a Comparative Randomized Study

Overview

50 adult patients scheduled for percutaneous nephrolithotomy in Sohag university hospitals will be devided in two groups one of them will receive Sonographic guided erector spinae plane block using 20 ml volume of bupivacaine 0.25 percent and the other will receive conventional analgesia of 0.1 mg/kg IV morphine

Interventions

  • Procedure Sonographic guided Erector spinae plane block
    Ultrasound guided plane block using 20 ml of 0.25% bupivacaine at the level of transverse process of T8
  • Drug Intravenous opioid
    0.1 mg/kg morphine intravenous pre operative

Primary outcome measures

  • Reduction of postoperative pain [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • ASA 1 to ASA 2 18 to 60 years

Exclusion criteria

  • patient refusal Significant neurological , psychiatric or neuromascular disease Drug abuse Pregnant or lactating women Suspected coagulopathy Morbid obesity Known allergy to some medications Septicaemia and local infection at block site

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06935006 · Soh-Med-22-06-35

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗